AI
FLGT icon

Atom Investors’s Fulgent Genetics FLGT Stock Holding History

Atom Investors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,965
Closed -$429K – 659
2025
Q3 		$429K Buy
18,965
+1,708
+10% +$35.2K 0.03% 379
2025
Q2 		$343K Buy
17,257
+3,087
+22% +$60.2K 0.03% 414
2025
Q1 		$239K Buy
+14,170
New +$241K 0.03% 390
2024
Q2 		– Sell
-17,672
Closed -$383K – 543
2024
Q1 		$383K Buy
+17,672
New +$439K 0.05% 374

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Atom Investors's FLGT Position: Q4 2025 in Review

Atom Investors sold out of Fulgent Genetics (FLGT) in Q4 2025, closing a stake of 18,965 shares — an estimated $429K sold.

Atom Investors first reported a position in FLGT in Q1 2024 and held it in 4 quarters. The position peaked at $429K in Q3 2025. 179 funds tracked by Wall St. Rank hold FLGT as of Q4 2025.

  • Atom Investors reported no remaining Fulgent Genetics position as of Q4 2025 after selling out during the quarter.
  • Atom Investors sold 18,965 Fulgent Genetics shares in Q4 2025, an estimated $429K.
  • Atom Investors first reported a position in Fulgent Genetics in Q1 2024 and held it in 4 quarters.
  • Atom Investors's Fulgent Genetics position peaked at $429K in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2025.

Based on Atom Investors's 13F filing for Q4 2025, filed 17 Feb 2026.